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Abstract
Background: For neurons to function correctly in neuronal circuitry they must utilize appropriate neurotransmitters.
However, even though neurotransmitter specificity is one of the most important and defining properties of a neuron we
still do not fully understand how neurotransmitter fates are specified during development. Most neuronal properties are
determined by the transcription factors that neurons express as they start to differentiate. While we know a few
transcription factors that specify the neurotransmitter fates of particular neurons, there are still many spinal neurons for
which the transcription factors specifying this critical phenotype are unknown. Strikingly, all of the transcription factors
that have been identified so far as specifying inhibitory fates in the spinal cord act through Pax2. Even Tlx1 and Tlx3,
which specify the excitatory fates of dI3 and dI5 spinal neurons work at least in part by down-regulating Pax2.
Methods: In this paper we use single and double mutant zebrafish embryos to identify the spinal cord functions of Evx1
and Evx2.
Results: We demonstrate that Evx1 and Evx2 are expressed by spinal cord V0v cells and we show that these cells
develop into excitatory (glutamatergic) Commissural Ascending (CoSA) interneurons. In the absence of both Evx1 and
Evx2, V0v cells still form and develop a CoSA morphology. However, they lose their excitatory fate and instead express
markers of a glycinergic fate. Interestingly, they do not express Pax2, suggesting that they are acquiring their inhibitory
fate through a novel Pax2-independent mechanism.
Conclusions: Evx1 and Evx2 are required, partially redundantly, for spinal cord V0v cells to become excitatory
(glutamatergic) interneurons. These results significantly increase our understanding of the mechanisms of neuronal
specification and the genetic networks involved in these processes.
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Background
Hundreds of millions of people across the world are af-
fected by neurological diseases and injuries. Understand-
ing how functional neuronal circuitry is established in
the vertebrate central nervous system (CNS) is essential
for developing better treatments for these conditions.
How neuronal circuitry develops is also a fundamental
question in developmental neuroscience. To answer this
question, we need to identify how the functional proper-
ties of distinct neurons are specified; since these proper-
ties determine which circuits the neurons participate in,
the functional roles that the neurons have within those
circuits and the resulting outputs of the circuitry. The
spinal cord is a powerful system for establishing funda-
mental principles of neuronal fate specification, function
and circuit assembly, as it is relatively simple and experi-
mentally tractable compared to the brain. This has en-
abled considerable progress in establishing the functions
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of different ventral spinal cord interneurons in loco-
motor circuitry (e.g. [1–9]). However, we still know rela-
tively little about how the functional properties of these
cells are determined.
For neurons to function correctly they must
synthesize and utilize correct neurotransmitters.
Within neuronal circuitry, if they inhibit rather than
excite their synaptic partners, or vice versa, then the
behaviors and functional outputs of those circuits will
be dramatically disturbed, and may give rise to patho-
logical conditions. For example, disruptions in the
balance of excitatory and inhibitory neurons in the
CNS have been implicated in epilepsy, autism, Alzhei-
mer’s and many other neurological disorders (e.g.
[10–13]). However, even though neurotransmitter spe-
cificity is one of the most important and defining
properties of a neuron we still do not fully under-
stand how neurotransmitter fates are specified during
development.
Many neuronal properties are determined by the
transcription factors that cells express as they start to
differentiate. We already know a few transcription
factors (e.g. Ptf1a, Lhx1, Lhx5, Lbx1, Pax2) that spe-
cify the inhibitory (GABAergic and/or glycinergic)
fates of several subsets of spinal interneurons [14–18].
Strikingly, most of these transcription factors function in
dorsal spinal neurons and all of them act through Pax2
[14–21]. In contrast, we only know two transcription fac-
tors, Tlx1 and Tlx3, that are required for the specification
of excitatory (glutamatergic) fates and these are only
expressed in dorsal dI3, dI5 and DILB cells [15, 16, 22].
Interestingly, Tlx1 and Tlx3 determine the glutamatergic
fates of dI3 and dI5 cells at least in part by down-
regulating Pax2 [15]. These results suggest that Pax2 is a
crucial player in neurotransmitter fate specification with
its presence being required for inhibitory fates and its
absence required for excitatory fates. However, we still
do not know which transcription factors regulate the
neurotransmitter fates of many excitatory spinal
neurons, including those in the ventral spinal cord,
whose correct functional specification is essential for
locomotion.
In this paper we identify two transcription factors,
Evx1 and Evx2, which are required for a subset of ex-
citatory fates in the ventral spinal cord. In mammals,
the spinal cord expression of Evx1 and Evx2 is re-
stricted to a population of cells located in an inter-
mediate dorso-ventral position corresponding to V0
cells (e.g. [23–28]). V0 cells are post-mitotic cells that
form from the p0 (Dbx1-positive, Nkx6.2-negative)
progenitor domain [23, 27–29]. These cells develop
into interneurons that are important components of
locomotor circuitry and they can be subdivided into
an Evx1-positive sub-population called V0v cells and
an Evx1-negative sub-population called V0D cells.
These names reflect the fact that V0v cells form more
ventrally than V0D cells (e.g. [23–28, 30–34]). Evx2 is
expressed in a similar pattern to Evx1 in the mouse
CNS, suggesting that it may also be expressed by V0v
cells. This is consistent with the observation that
Evx2 spinal cord expression is lost in mouse Evx1
mutants [23]. However, co-expression of Evx1 and
Evx2 in the mouse spinal cord has not yet been dem-
onstrated [24].
In mammals, both V0v and V0D interneurons are cru-
cial for correct left-right alternation during locomotion,
with V0v cells in particular being required for hindlimb
left-right alternation during fast locomotion [9, 34].
While the functions of V0 cells in specific behaviors
have so far only been assayed in mouse, these cells have
highly conserved commissural axon trajectories in all
animals examined so far ([23–28, 32, 33, 35, 36]; this
paper), suggesting that their functional properties are
likely to be highly conserved across the vertebrate
lineage. However, when we started this work the
neurotransmitter phenotype of V0v cells had not been
identified.
In zebrafish, evx1 and evx2 are expressed in a similar
intermediate dorsal-ventral spinal cord position to that
observed in other vertebrates [26, 32, 33], although
again, co-expression of these two genes has not previ-
ously been demonstrated. In this paper, we confirm that
evx1 and evx2 are co-expressed by V0v cells and we
show that V0v cells are glutamatergic and have a Com-
missural Ascending (Comissural Secondary Ascending
or CoSA) morphology. We also provide the first analysis
of evx1;evx2 double mutants in any vertebrate and the
first analysis of the spinal cord phenotype of evx2 mu-
tants. Significantly, we demonstrate that Evx1 and Evx2
are required, partially redundantly, to specify the gluta-
matergic fates of V0v cells. Given that we know so little
about how excitatory fates are specified in the spinal
cord and particularly the ventral spinal cord, these
findings add considerably to our understanding of CNS
circuit development.
In the absence of both Evx1 and Evx2, V0v cells
lose their glutamatergic fates but other functional
characteristics like soma/cell body morphology and
axon trajectory are unchanged. In addition, and in
contrast to a previously described mouse Evx1 mutant
[23], these cells do not express markers of neighbor-
ing cell types. This suggests that V0v cells are not
transfating into a different class of neuron; they have
just changed some of their functional properties.
Strikingly, in evx1;evx2 double mutants V0v cells
become inhibitory, but they do not express Pax2,
suggesting that they are acquiring their inhibitory
fates through a novel Pax2-independent mechanism.
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Methods
Ethics approval
All zebrafish experiments in this research were approved
either by the UK Home Office or by the Syracuse Uni-
versity IACUC committee.
Zebrafish husbandry and fish lines
Zebrafish (Danio rerio) were maintained on a 14 h light/
10 h dark cycle at 28.5 °C and embryos were obtained
from natural, paired and/or grouped spawnings of wild-
type (WT) adults (AB, TL or AB/TL hybrids), identified
heterozygous or homozygous Tg(slc17a6:EGFP) (used to
be called Tg(vGlut2a:EGFP); [36, 37]), Tg(evx1:EGFP)SU1
or Tg(evx1:EGFP)SU2 adults, double heterozygous
evx1i232;evx2sa140 mutants or double heterozygous
evx1i232;evx2sa140 mutants that also carried one of the
Tg(evx1:EGFP) lines (see below). Embryos were reared at
28.5 °C and staged by hours post fertilization (h), days post
or prim staging/or prim staging [38].
The evx1i232 mutation has been described before [39].
The evx2sa140 mutant was received from the Wellcome
Trust Sanger Centre, (https://www.sanger.ac.uk/sanger/
Zebrafish_Zmpbrowse). Both mutations produce a single
base pair change (a C to a T in the case of evx2sa140) that
results in a premature stop codon before the homeobox
([39]; Fig. 1a). Therefore, the truncated proteins, if
formed, will lack DNA binding domains. The evx2sa140
mutation creates a BfaI recognition site that enables us
to genotype individual fish and embryos (see below;
Fig. 1b). In this paper we demonstrate that the evx2sa140
allele does not make Evx2 protein (Fig. 1c), strongly sug-
gesting that it is a null allele. The evx1i232 mutant is also
probably a null allele [39]. However, in contrast to the
evx1i232 mutant which is viable, the evx2sa140 mutant is
embryonic lethal (see Results and Additional file 1:
Results).
Genotyping
Genotyping of mutant alleles was performed on both live
adults and fixed embryos using DNA extracted from fin
clips and dissected heads respectively. Fin clipping and
evx1 genotyping were performed as in [39]. To extract
DNA from embryos, heads were removed in 80 % gly-
cerol / 20 % PBS with insect pins. Embryonic trunks
were stored in 70 % glycerol / 30 % PBS at 4 °C for later
analysis. Heads were incubated in 50 μL of Proteinase K
buffer solution (1 M Tris-HCl, pH 8.2; 0.5 M EDTA;
1 M NaCl; 20 % SDS; 10 mg/ml Proteinase K) for 2 h at
55 °C. Proteinase K was heat inactivated at 100 °C for
10 min and tubes were centrifuged for 20 min at
13,000 rpm. DNA was precipitated with 100 % ethanol
at -20 °C overnight, centrifuged to pellet the DNA and
re-suspended in 20 μL of water. 2 μL of DNA was used
for each PCR.
The evx2sa140 mutation creates a BfaI recognition site. A
genomic region flanking the mutation site was PCR ampli-
fied using the following conditions: 94 °C for 60 s, followed
by 5 cycles of 92 °C for 30 s, 54 °C for 30 s, 72 °C for 60 s;
followed by 40 cycles of 92 °C for 20 s, 52 °C for 30 s, and
72 °C for 60 s, followed by a final extension at 72 °C for
5 min. Forward primer: GTAATGCGATCCCAAAACG.
Reverse primer: TTATTTTAGATTTGGCAATGG.
PCR products were digested with BfaI and analysed on
a 1 % agarose gel. The WT product is 454 bp, whereas
the mutant product is cut into 218 bp and 236 bp frag-
ments. These fragments are close enough in size that
they are usually detected as one band on an agarose
electrophoresis gel (Fig. 1b).
Creation of Tg(evx1:EGFP) lines
Potential evx1 enhancer regions were identified by mul-
tispecies sequence comparisons using the global align-
ment program Shuffle-LAGAN [40] and visualized using
VISTA [41]. Zebrafish (Danio rerio) evx1 genomic
sequence (ENSDARG00000099365) and orthologous
sequences from human (ENSG00000106038) and mouse
(ENSMUSG00000005503) were obtained from Ensembl
(http://www.ensembl.org). Zebrafish sequence was used
as the baseline and annotated using exon/intron infor-
mation from Ensembl. The alignment was performed
using a 100 bp window and a cutoff score of 70 % iden-
tity. A multi-species comparison of approximately 23Kb
of Danio rerio genomic DNA sequence containing evx1
and extending 5 Kb into flanking regions revealed high
conservation in both coding and non-coding sequences
among compared species. We identified three Conserved
Non-coding Elements (CNEs) located 5’ and 3’ to evx1.
The first is located 79 bp upstream of zebrafish evx1
coding sequence and extends over 100 bp. The other
two are located 3' to evx1. One is 2354 bp downstream
of the stop codon and is 184 bp long whereas the other
is 2979 bp downstream of the stop codon and extends
over 140 bp (Fig. 1d). One amplicon encompassing these
two 3’ CNEs and the intervening sequence (1.34 Kb) was
PCR-amplified from genomic DNA. Forward primer:
AAGATTGGAATGGAATGTCT. Reverse primer: GCA
TTTTCGCCTTTGCATCA.
The Tg(evx1:EGFP)SU1 line was generated by cloning
this 3’ CNE amplicon into the pDONRTMP4-P1R vector
from Invitrogen using Gateway technology [42, 43]. The
final construct was assembled using the pENTRbasegfp
plasmid and the pCSDest2 vector [44]. This resulted in a
vector containing Tol2:1.3Kb 3’ zfish evx1:ßcarp minimal
promoter:EGFP:Tol2.
The same 3’ CNE amplicon was used to generate the
Tg(evx1:EGFP)SU2 line. In this case, the GAL4VP16;UAS-
EGFP cassette was taken from the pBGAL4VP16;UAS-
EGFP plasmid [45] and cloned into a middle entry vector
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Fig. 1 V0v cells co-express evx1 and evx2. a Schematic of Evx2 showing exon boundaries (dotted lines), homeobox-domain (pink) and location of
evx2sa140 mutation (red arrow). b Examples of genotyping WT, heterozygous and homozygous evx2sa140 mutant embryos using gel electrophoresis
(see methods). The two fragments from the mutant allele restriction product run at the same position on the gel. c, e-h lateral views, dorsal up,
anterior left, of spinal cord at 24 h (f-h) or 27 h (c & e). c Evx2 immunohistochemistry on WT (top panel) and homozygous evx2sa140 mutant (bottom
panel) embryos. Stars indicate Evx2-expressing cells. Mutant embryos have no Evx2 expression. d Schematic showing Shuffle-LAGAN analysis of evx1
genomic region with zebrafish sequence as baseline compared to orthologous regions in mouse and human genomes. Conserved coding sequences are
indicated in blue, arrow indicates 5'-3' orientation. CNEs in 3’ region are indicated in pink. The region amplified to create transgenic lines is indicated with
red dotted lines. e-h Double staining for (e) EGFP (green) and Evx2 (red) in Tg(evx1:EGFP)SU1 embryos, (f) EGFP (green) and evx1 (red) in Tg(evx1:EGFP)SU1
embryos, (g) evx1 (red) and evx2 (green) in WT embryos, (h) EGFP (green) and dbx1a (red) in Tg(evx1:EGFP)SU1 embryos (i and iii) and EGFP (green) and
dbx1b (red) in Tg(evx1:EGFP)SU1 embryos (ii and iv). In e-g and h_iii - h_iv, merged and single channel views are provided. White crosses indicate cells that
only express evx1. In (f) these probably represent cells that have just started to express evx1 as there is a delay in expression of EGFP.
White stars in h indicate double-labelled cells. Three wider panels at bottom of h (iii and iv) are magnified single-confocal-plane views of
white dotted rectangle regions in panels h_i and h_ii respectively. Thin panel on RHS in each case shows a cross-section projection (slice)
created in Image J confirming that GFP expression is lateral to dbx expression. Scale bar: 50 μm (c & e-h)
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from Invitrogen [42, 43]. An oligonucleotide containing
the cfos minimal promoter sequence [46] plus 17 bp of the
5’ arm of GAL4 was synthesized and used with a RVeGF-









This PCR product was used to generate a second PCR
product using the primer FWattB1cfos: GGGGACAAG
TTTGTACAAAAAAGCAGGCTCACTCATTCATAAA
ATCGCTT and the RVeGFPAttb2 primer.
The final amplicon was cloned into pDONR™221 using
gateway technology. This middle entry vector was used
to generate a final vector containing Tol2:1.3Kb 3’ zfish
evx1:cfos minimal promoter:GAL4VP16;UAS-EGFP:Tol2.
Each of these plasmids was separately co-injected with
transposase mRNA into 1-2 cell embryos as described
by [47]. Embryos were raised to adulthood and out-
crossed to identify founders. In each case one stable
transgenic line was generated. The Tg(evx1:EGFP)SU2 or
Tg(1.3 kb evx1:cfos:GAL4-UAS:EGFP) line has the advan-
tage that it contains a GAL4-UAS cassette to amplify
EGFP expression. This facilitates visualization of axons.
However, this line has a slightly more variegated
expression than the Tg(evx1:EGFP)SU1 or Tg(1.3Kb
evx1:ßcarp:EGFP) line, presumably because of stochas-
tic silencing of the construct due to the GAL4-UAS
sequences [48]. In contrast the Tg(evx1:EGFP)SU1 line
labels all V0v cells more consistently, but the EGFP
expression is slightly weaker and we were never able
to obtain evx1-/-;evx2-/- double mutant embryos that
contained this transgene, even though we could ob-
tain evx1-/-;evx2+/+ and evx1-/-;evx2+/- embryos. This
suggests that the Tg(1.3Kb evx1:ßcarp:EGFP) construct
integrated close to the WT evx2 allele.
Morpholino injection
Approximately 5 nl of a 1:1 combination of two Evx2
ATG Morpholino antisense oligonucleotides (MOs) at
1.25 mg/ml each were injected into 1-2 cell embryos
(evx2-1 MO: TTCTTTTCTTATCCTCTCCATCATG;
evx2-2 MO: AATCCAAAGTCCCAGGGCTGGTGCT).
In all cases, we confirmed that the MOs had completely
knocked down Evx2 using immunohistochemistry for
zebrafish Evx2.
Expression profiling V0v cells
To determine which neurotransmitters V0v cells ex-
press and to identify additional transcription factors
expressed by these cells, different combinations of
spinal cord and trunk cells were extracted from live
transgenic zebrafish embryos at 27 h using fluores-
cence activated cell-sorting (FACS). Prior to FACS,
embryos were prim-staged, deyolked, dissected and
dissociated as in [49, 50]. In all cases, the heads
were removed to ensure that only trunk or spinal
cord cells were collected. Pure populations of cells
were obtained using combinations of the following
transgenic lines: Tg(elav13:EGFP), Tg(evx1:EGFP)SU1,
Tg(pax2a:GFP), Tg(Xla.Tubb:DsRed (formerly
Tg(NBT:DsRed)), Tg(vsx2:DsRed) and Tg(gata1:GFP) [8,
51–54]. Trunk samples correspond to FAC-sorted
trunk cells (spinal cord and other tissues). All neuron
samples are EGFP-positive cells from Tg(elav13:EGFP)
trunks. V0v neurons are EGFP-positive cells from Tg(ev-
x1:EGFP)SU1 trunks. V1 neurons are double-positive
EGFP-positive, DsRed-positive cells from Tg(pax2-
a:GFP);Tg(Xla.Tubb:DsRed) trunks. V2a neurons are
double-positive DsRed-positive, EGFP-positive cells from
Tg(vsx2:DsRed);Tg(elavl3:EGFP) trunks. V2b + KA neu-
rons are double-positive EGFP-positive, DsRed-positive
cells from Tg(gata1:GFP);Tg(Xla.Tubb:DsRed) trunks.
Total RNA was extracted using an RNeasy Micro Kit
(Qiagen, 74004). RNA quality and quantity was assayed
on an Agilent 2100 Bioanalyser (RNA 6000 Pico Kit,
Agilent, 5067-1513), before converting to fluorescently-
labelled cDNA (Ovation Pico WTA System V2, Pico,
3302) and hybridizing to a custom-designed Agilent
microarray (EMBL Genomics Core, Heidelberg). Details
of this microarray will be described elsewhere, along with
the characterization of additional genes identified from
these analyses. Data pre-processing and normalization
was performed using Bioconductor software (https://
www.bioconductor.org/). Two-class eBayes and three-
class ANOVA analyses were performed using GEPAS soft-
ware (Tárraga, (2008)). All reported statistics were cor-
rected for multiple testing (Benjamini and Hochberg
(1995)).
in situ hybridization
Embryos were fixed in 4 % paraformaldehyde and single
and double in situ hybridizations were performed as pre-
viously described [55, 56]. RNA probes were prepared
using the following templates, dbx1a and dbx1b [57],
evx1 [58], evx2 [32], eve1 [59], pax2a, pax2b, pax8 [60]
and eng1b [14]. To determine neurotransmitter pheno-
types we used probes for genes that encode proteins that
transport or synthesize specific neurotransmitters. A
mixture of two probes (glyt2a and glyt2b) for slc6a5
(previously called glyt2) was used to label glycinergic
cells [61, 62]. slc6a5 encodes for a glycine transporter
necessary for glycine reuptake and transport across the
plasma membrane. A mixture of two probes to gad1b
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(previously called gad67, probes used to be called
gad67a and gad67b) and one probe to gad2 (previously
called gad65) was used to label GABAergic cells [61, 62].
gad1b and gad2 encode for glutamic acid decarboxy-
lases, necessary for the synthesis of GABA from glutam-
ate. A mixture of slc17a6b (formerly called vglut2.1) and
slc17a6a (formerly called vglut 2.2) probes was used to
label glutamatergic cells [61, 62]. These genes encode
proteins responsible for transporting glutamate to the
synapse. In all of these cases, a mix of equal concentra-
tions of the relevant probes was used [61, 62]. We also
used slc32a1 (formerly called viaat), which encodes for a
vesicular inhibitory amino acid transporter, to label all
inhibitory cells [8].
The DNA template for the skor2 (ZDB-GENE-060825-
57) probe was generated by PCR-amplifying the 3’ region
of skor2 from cDNA using a reverse primer containing a
T3 promoter sequence at the 5’ end (indicated in italics
below). Total RNA was extracted by homogenizing 50-
100 mg of 27hpf wild-type zebrafish embryos in 1 mL of
TRIzol reagent (Ambion, 15596-026). cDNA was
synthesized using Bio-Rad iScript Reverse Transcription
Supermix kit (Bio-Rad, 170-8891). A 50 μL PCR was as-
sembled containing 5 μL cDNA and 1 unit of Phusion
High-Fidelity DNA Polymerase (NEB, M0530L). PCR
conditions were: 94 °C for 3 min followed by 35 cycles
of 94 °C for 30 s, 56.5 °C for 30 s, 72 °C for 1.5 min and
then a final extension step of 72 °C for 10 min. PCR




ZFIN Identification numbers are provided for all genes
in Additional file 1: Table S2.
Immunohistochemistry
Primary antibodies used were rabbit anti-Evx2 (a kind
gift from Dr Higashijima, described in Satou et al., 2012,
raised against the first 168 amino acids of zebrafish
Evx2, a region with no significant homology to zebrafish
Evx1, 1:300), mouse anti-GFP (Roche Applied Science,
11814460001, 1:500), rabbit anti-GFP (Molecular Probes
A6465, 1:500) and mouse anti-Pax2 (Covance PRB-276P
1:300). The Pax2 antibody recognizes both Pax2a and
Pax2b in zebrafish [14]. Antibodies used for fluorescent
in situ hybridization were mouse anti-Dig (Jackson
ImmunoResearch 200-002-156, 1:5000) and rabbit
anti-Flu (Invitrogen A889, 1:2500). These were detected
with Invitrogen Tyramide kits #12 and #5. Secondary
antibodies used were Alexa Fluor 568 goat anti-rabbit
(Molecular Probes A11036, 1:500), Alexa Fluor 488 goat
anti-rabbit (Molecular Probes A11034, 1:500) and Alexa
Fluor 488 goat anti-mouse (Molecular Probes A11029,
1:500).
Embryos for immunohistochemistry were treated with
acetone for 15 min (24 h embryos) or 20 min (30 h
embryos) to permeabilize them, washed for 5 min in
distilled water, then washed 2 x 10 min in PBS. Embryos
were treated with Image-iT Signal Enhancer (Invitrogen,
I36933) for 30 min, then incubated in block solution
(2 % goat serum, 1 % BSA, 10 % DMSO and 0.5 % Tri-
ton) for 1 h at room temperature followed by incubation
in primary antibody in fresh block solution at 4 °C over-
night. Embryos were washed with PBT (PBS + 0.1 %
Triton) for 2 h at room temperature and incubated with
secondary antibody in block solution at 4 °C overnight.
Embryos were then washed with PBT for at 2 h at room
temperature and stored in 2 % DABCO (Acros Organics,
AC11247-1000).
For 3,3’- diaminobenzidine (DAB) staining, after incu-
bation with primary antibody, samples were incubated in
fresh blocking solution with goat anti-rabbit IgG (Cov-
ance SMI-5030C, 1:200) at 4 °C overnight. Embryos
were then washed with PBT for 2 h and incubated with
rabbit PAP (Covance SMI-4010 L, 1:200) in block
solution at 4 °C overnight. Embryos were then washed in
PBT for 2 h. Staining was performed using Sigma Fast
3,3’- diaminobenzidine tablets (Sigma, D4293).
Imaging
Embryos were mounted in 70 % glycerol, 30 % PBS and
DIC pictures were taken using an AxioCam MRc5
camera mounted on a Zeiss Axio Imager M1 compound
microscope. Fluorescent images were taken on a Zeiss
LSM 710 confocal microscope. Images were processed
using Adobe Photoshop software (Adobe, Inc) and
Image J software (Abramoff et al., 2004). In some cases
different focal planes were merged to show labeled cells
at different medial lateral positions in the spinal cord.
Cell counts and statistics
In all cases, cells counts are for both sides of a five-
somite length of the spinal cord adjacent to somites 6-
10. Most values are an average of at least 5 embryos. Ex-
ceptions are the skor2 + Tg(evx1:EGFP) double-labeling
experiments, the skor2 + Tg(slc17a6:EGFP) double-
labeling experiments and the pax2a and eng1b in situ
hybridization results. In all of these cases 4 embryos
were counted. Results were analyzed using the student’s
t-test; Error bars indicate standard deviation.
Results
Zebrafish V0v cells express evx1 and evx2
In mouse, Evx1 is expressed in V0v cells and while
double-labeling experiments have not yet been per-
formed, the data suggest that Evx2 is probably co-
expressed by these same cells [23, 24, 27, 28]. Previous
reports described evx1 and evx2 expression in a similar
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region of zebrafish spinal cord [32, 33] but didn’t deter-
mine whether these genes are co-expressed or the spe-
cific cell types that express them.
To address these questions, we performed single and
double in situ hybridization experiments and found that
zebrafish evx1 and evx2 are co-expressed in an inter-
mediate region of the dorso-ventral axis of the spinal
cord (Figs. 1g and 2a & i). We further confirmed that
evx1 and evx2 are co-expressed in zebrafish spinal cord
using an EGFP line, Tg(evx1:EGFP)SU1. We constructed
this line using enhancer sequences identified down-
stream of evx1 (see methods & Fig. 1d). We confirmed
that the stable line recapitulates endogenous evx1 ex-
pression (Fig. 1f ) and also shows co-expression of EGFP
and Evx2 protein (Fig. 1e). Interestingly, at 27 h, all of
the cells that express Evx2 also express EGFP (and hence
evx1) (Fig. 1e), however, a few cells express EGFP but
not Evx2. Similarly, at 24 h, a few cells express evx1 but
not evx2 (Fig. 1g). This is consistent with earlier reports
that suggest that evx1 may be expressed in the spinal
cord slightly earlier than evx2 [32, 33], although we can-
not rule out the possibility that there is a very small sub-
set of evx1-expressing V0v cells that do not express
evx2.
V0 cells develop from the p0 progenitor domain,
which expresses dbx1 [28, 63]. Therefore, to confirm
that evx1/2-expressing cells are V0v cells we per-
formed EGFP immunohistochemistry and in situ
hybridization for dbx1a and dbx1b in Tg(ev-
x1:EGFP)SU1 embryos. We found that zebrafish evx
genes are expressed lateral to cells expressing both of
these dbx1 genes, as would be predicted for cells de-
veloping from the p0 domain. In addition, dbx1a and
dbx1b expression persists in some EGFP-positive cells
(Fig. 1h), suggesting that these genes continue to be
expressed by V0v cells for a short while after they be-
come post-mitotic.
Zebrafish also have a third evx gene, called eve1, but
earlier studies suggested that this gene is not expressed
in the spinal cord [26, 32, 59, 64]. We confirmed this by
Fig. 2 Expression of evx and eng1b genes in evx1;evx2 double mutant embryos. Lateral views of zebrafish spinal cord at 24 h (a-f, i & j) or 30 h
(g, h, k & l ). Anterior left, dorsal up. a-j in situ hybridization for each gene indicated. e-h strong ventral expression is in muscle pioneer cells,
expression in more individual dorsal cells corresponds to spinal cord V1 cells. k & l immunohistochemistry for Evx2. m-p Average number of cells
(y-axis) expressing indicated marker in spinal cord region adjacent to somites 6-10 in WT embryos and evx1 and evx2 single and double mutants
(x-axis) at 24 h (m-o) or 30 h (p). Values are shown as mean +/- standard deviation (values are provided in Table 1). There are no evx2-positive
cells in the double mutants (n). In each case at least 5 embryos were counted, except for eng1b where 4 embryos were counted. Statistically
significant differences (P < 0.05) from WT values are indicated with brackets and stars. P values for these and other comparisons (e.g differences
between single and double mutants) are provided in Table 1. Scale bar: 50 μm (a-l)
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examining eve1 expression at multiple stages of spinal
cord development (every two somites from 2-somites -
24 h; Fig. 3 and data not shown). In all cases we never saw
any spinal cord expression, only expression in the devel-
oping tailbud. To check whether eve1 expression is altered
in the absence of Evx1 and/or Evx2 we also examined ex-
pression in evx1;evx2 double mutants. However, we saw
no change in eve1 expression in these double mutants
(Fig. 3f). Therefore, this gene is not considered further in
this paper. We also confirmed that no additional evx genes
exist in zebrafish (Additional file 1: Results and Figure S1).
Zebrafish V0v cells develop into commissural ascending
interneurons
In mouse, V0v cells develop commissural axons that ascend
(grow rostrally) for one to four somite segments [23]. We
used both the Tg(evx1:EGFP)SU1 transgenic line and an
additional transgenic line that has stronger expression in
V0v cell axons,Tg(evx1:EGFP)SU2 (see methods), to examine
the morphology of zebrafish V0v cells. We found that by
27-30 h, almost all of the cells have extended their axons
ventrally and have at least started to cross the midline to
the other side of the spinal cord (Fig 4a & b). By 48 h, most
of the cells have reached the other side of the spinal cord
and have turned towards the head, giving them a clear
commissural ascending, or CoSA [65, 66], morphology
(Fig. 4c & f).
V0v cells are glutamatergic
In wild-type mouse spinal cords, V0 cells develop into both
inhibitory (glycinergic or GABAergic) and excitatory (gluta-
matergic) interneurons [27, 28, 36], but when we started
this project the neurotransmitter phenotype of V0v cells
had not been established. Zebrafish have both excitatory
and inhibitory CoSA interneurons [61, 62], so we could not
infer the neurotransmitter properties of V0v cells from their
morphology alone. Therefore, we performed double-labeling
experiments to establish the neurotransmitter fates of these
cells. Double immunohistochemistry for Evx2 and EGFP in
the Tg(slc17a6:EGFP) line which labels glutamatergic inter-
neurons in the zebrafish spinal cord [37, 67] revealed that
all of the Evx2-positive cells are glutamatergic (Fig. 5a). As
expected, not all of the glutamatergic cells express Evx2,
since there are several excitatory cell types in the zebrafish
spinal cord and only V0v cells express Evx2. In addition, in
situ hybridization for slc17a6 (vglut) genes, markers of glu-
tamatergic cells (see methods for more details) combined
with EGFP immunohistochemistry in Tg(evx1:EGFP)SU1
embryos also confirmed that evx1-expressing cells are
glutamatergic (Fig. 5b). We also examined if evx1 is co-
expressed with markers of any other spinal cord neuro-
transmitter fates. Using double in situ hybridization we
found no co-expression between evx1 and markers for gly-
cinergic or GABAergic markers (data not shown). We also
observed no double-labeled cells when we performed EGFP
immunohistochemistry and in situ hybridization for
slc32a1 (formerly called viaat) which labels all inhibitory
neurons [8, 68, 69] in Tg(evx1:EGFP)SU2 embryos (Fig. 5c).
Consistent with these analyses, when we FAC-sorted and
expression profiled EGFP-labeled V0v cells using the
Tg(evx1:EGFP)SU1 line we found that these cells express
markers of glutamatergic fates (slc17a6a (formerly called
vglut2.2) and slc17a6b (formerly called vglut2.1)) and do
not express either glycinergic markers (slc6a9 (formerly
called glyt1) or slc6a5 (formerly called glyt2)) or GABAergic
markers (gad1b or gad2) (Fig. 5d & e).
Zebrafish V0v cells do not express Pax2
As discussed above, Pax2 is an important regulator of
inhibitory spinal cord fates [14–21]. Given that we
had shown that V0v cells are excitatory (glutamater-
gic) and we had not observed any inhibitory V0v cells
Fig. 3 eve1 is not expressed in zebrafish spinal cord in WT or evx1;evx2
double mutant embryos. Lateral views of in situ hybridization for eve1
in 4-somite (a), 8-somite (b), 12-somite (c), 16-somite (d) and 24 h
(e & f) embryos. a-e WT; (f) evx1;evx2 double mutant. Anterior is left
and dorsal up. Expression is seen in the tail bud region but not the
spinal cord. Embryos in (e & f) were over-stained to check that there
was no weak expression in the spinal cord. The only specific staining
seen was at the end of the tail (inset in right bottom corner). The rest
is background staining from over-staining. Scale bar: 100 μm
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(Figs 5a-e), we would not predict that V0v cells would
express Pax2. However, the literature contains contradict-
ory evidence as to whether evx1 and evx2 are co-expressed
with pax2 in the spinal cord [35, 58, 70, 71]. To resolve this
issue, we performed double-labeling experiments for evx1
and pax2 using several complementary approaches. These
included in situ hybridization for evx1 and immunohisto-
chemistry for Pax2, EGFP immunohistochemistry and in
situ hybridization for pax2a, pax2b and pax8 (three
highly-related pax genes that are co-expressed in zebrafish
spinal cord cells [14]) in Tg(evx1:EGFP)SU2 embryos and
double immunohistochemistry for EGFP and Pax2 in
Tg(evx1:EGFP)SU2 embryos. In all cases, we observed no
double-labeled cells, suggesting that evx1 and evx2 are not
co-expressed with pax2/ pax8 genes in zebrafish spinal
cord (Fig. 6g and data not shown). These analyses comple-
ment those of Satou and colleagues [36] who recently
reported that inhibitory V0 cells, which presumably corres-
pond to V0D cells, express Pax2, but Evx2-expressing cells
do not. Taken together, these data strongly suggest that
V0v cells do not express pax2 genes.
evx2sa140 is a null allele
To identify the functions of evx1 and evx2 in zebrafish
V0v cells we used evx1 and evx2 mutants (see Methods).
Our previous analyses suggest that evx1i232 is a null al-
lele [39]. The evx2sa140 mutation introduces a premature
stop codon just before the homeodomain, suggesting
that if a truncated protein is synthesized it will have no
DNA binding activity. However, it is possible that a trun-
cated protein might retain some function in the embryo.
To determine if any Evx2 protein is made in mutant em-
bryos, we used an Evx2 antibody that was made against
the first 168 amino acids of zebrafish Evx2 (which corre-
sponds exactly to the region upstream of the premature
stop codon in the evx2sa140 mutant allele). We found
that all of the WT (21/51) and heterozygous embryos
(20/51) had Evx2 antibody staining but all of the homo-
zygous mutants (10/51) did not (Fig. 1c). This strongly
suggests that the evx2 mutant allele does not produce
any protein and is a null allele.
evx2sa140 homozygous mutants are not viable
Unlike the zebrafish evx1 mutant, which is homozygous
viable [39], we never identified an adult evx2 homozygous
mutant (n = 262 fish from incrosses of heterozygous evx2
fish, P < 0.0001 using chi-squared test). However, we did
obtain fish homozygous for evx1 and heterozygous for
evx2 (17 fish identified from a total of 191 fish from
incrosses of heterozygous double mutants; P = 0.13 using
Fig. 4 V0v cells develop into CoSA interneurons. Immunohistochemistry for EGFP in Tg(evx1:EGFP)SU1 (a, b & e) or Tg(evx1:EGFP)SU2 (c, d, f & g)
embryos..a, f & g lateral views with dorsal up and anterior left of spinal cord at 27 h (a) or 48 h (f & g). b-e dorsal views with anterior left of
zebrafish spinal cord at 30 h (b) or 48 h (c-e). a-c & f WT, (d & g) evx1;evx2 double mutant, (e) evx1 mutant injected with evx2 morpholino.
b & c show increasing number of commissural axons crossing the spinal cord as development proceeds. d & e demonstrate that V0v axons are
still clearly commissural in the absence of Evx1 and Evx2. f & g show magnified views of commissural ascending V0v axons. White arrows (drawn
slightly to the right of the axon so that EGFP expression is still visible) indicate ascending axon trajectories. Scale bar: 50 μm (a-e) and 15 μm (f & g)
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chi-squared test). Our analyses of incrosses from identified
evx2 heterozygous fish suggest that evx2 mutant embryos
have no obvious morphological defects for the first few
days of development but that most of them die by larval
stages (see Additional file 1: Results).
V0v cells still form in evx1;evx2 double mutants
In mouse Evx1 mutants, expression of Evx2 is lost and
there is an increase in the number of cells expressing
the V1 marker En1. In addition, many of the cells that
would normally have expressed Evx1 develop axon tra-
jectories similar to V1 cells. Most strikingly their axons
change from being commissural to ipsilateral [23]. This
suggests that in the absence of Evx1, most mouse V0v
cells transfate to V1 cells.
In contrast, we found that in zebrafish evx1 mutants
there is only a small reduction in the number of cells ex-
pressing evx2 RNA and Evx2 protein in the spinal cord
Fig. 5 Neurotransmitter phenotypes of V0v cells. Lateral views of spinal cord at 27 h (a & b) or 30 h (c & f). All panels contain merged and single
channel views. Smaller images on RHS are single confocal planes of white box regions. Double and single-labeled EGFP-positive cells are indicated in
single confocal planes with stars and crosses respectively. a EGFP (green) and Evx2 (red) expression in Tg(slc17a6:EGFP) embryo. All Evx2-positive cells
co-express EGFP. b EGFP (green) and glutamatergic marker (slc17a6b & slc17a6a; red) expression in Tg(evx1:EGFP)SU1 embryo. Occasional single-positive
cells are indicated with crosses. These may be expressing glutamatergic markers at levels too low to detect (slc17a6 probes are weak in double-
labeling experiments). Remaining cells are double-labeled. c & f EGFP (green) and slc32a1 (red) expression in Tg(evx1:EGFP)SU2 WT (c) and evx1;evx2
double mutant (f) embryos. No V0v cells are inhibitory in WT embryos, but most V0v cells are inhibitory in double mutants (occasional single-labeled
cells are indicated with a cross in F). (d & e) Relative expression profiles of genes (names on right) indicative of neurotransmitter fates at 27 h. Columns
represent individual microarray experiments. Rows indicate relative expression levels as normalized data transformed to mean of zero and standard
deviation of +1 (highly-expressed, red) to -1 (weakly/not expressed, blue) sigma units. For details of how cells were isolated see methods. d Two-class
eBayes comparison of excitatory (class 1) versus inhibitory (class 2) cells. Mixing proportion measures posterior probability, or likelihood that genes are
differentially expressed (1 = highest probability of differential expression). e Three-class ANOVA comparison of V0v cells (class 3) versus trunk cells (class
1) and all post-mitotic neurons (class 2). P values test hypothesis that there is no differential expression between the 3 classes. V0v cells express
glutamatergic markers slc17a6a and slc17a6b and do not express glycinergic or GABAergic markers in both comparisons. Scale bar: 50 μm (a-c & f)
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Fig. 6 V0v cells do not express Pax2 in WT or evx1;evx2 double mutant embryos. Lateral views of zebrafish spinal cord at 24 h (a-d) or 30 h (g &
h). Anterior left, dorsal up. a & b in situ hybridization for pax2a. c & d immunohistochemistry for Pax2. The Pax2 antibody recognizes both Pax2a
and Pax2b. e & f Average number of cells (y-axis) expressing these markers (indicated in each case) in spinal cord region adjacent to somites 6-10
in WT embryos and evx1 and evx2 single and double mutants (x-axis). Values are shown as mean +/- standard deviation (values are provided in
Table 1). In each case at least 5 embryos were counted, except for pax2a where 4 embryos were counted. P values for all comparisons are
provided in Table 1. g & h EGFP (green) and Pax2 (red) expression in Tg(evx1:EGFP)SU2 WT (g) and evx1;evx2 double mutant (h) embryos. No V0v
cells express Pax2 in either case. Panels on RHS are magnified single-confocal-plane views of white dotted rectangle regions in panels G and H
respectively. White crosses indicate single-positive GFP cells. Scale bar: 50 μm (a-d) & 40 μm (g-h)
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(approximately a 22 % reduction for evx2 at 24 h and a
32 % reduction for Evx2 at 30 h; Fig. 2c, l & n; Table 1),
although expression of evx2 RNA is lost completely in
evx1;evx2 double mutants (Fig. 2b & n; Table 1). In con-
trast, there is no difference in evx1 expression in evx1 or
evx2 single mutants when compared to WT siblings, al-
though approximately 47 % of V0v cells lose expression
of evx1 in double mutants (Fig. 2j & m; Table 1). Con-
sistent with the down-regulation of evx1 in double mu-
tants, we observe a 30 % reduction in the number of
EGFP-labeled V0v cells in double mutant Tg(ev-
x1:EGFP)SU2 embryos (22.9 +/- 3.4 cells in WTs; 16.0 +/-
5.5 cells in double mutants). However, strikingly, most
V0v cells are still labeled with EGFP and these cells have
a normal commissural ascending CoSA morphology
(Fig. 4d & g). Unfortunately, we were never able to iden-
tify double mutant embryos that carried the Tg(ev-
x1:EGFP)SU1 transgene, suggesting that this transgene
probably integrated in the vicinity of the WT evx2 allele
(see methods). However, consistent with our results
using the Tg(evx1:EGFP)SU2 transgenic line, when we
injected evx2 ATG morpholinos, at a concentration that
eliminates Evx2 protein, into evx1 single mutant Tg(ev-
x1:EGFP)SU1 embryos, we also observed EGFP-labeled
V0v cells with normal CoSA axon trajectories (Fig. 4e).
Consistent with this persistence of V0v cells, we also
found no change in the number of eng1b-expressing
spinal cord cells in evx1 and evx2 single or double mu-
tants compared to WT embryos at 24 h. If anything, we
observed a slight reduction in the number of eng1b cells
in the double mutants, although this was not statistically
significant (Fig. 2f & o, Table 1). To further confirm that
V0v cells were not adopting a V1 fate and turning on
eng1b expression, we repeated this experiment at 30 h.
We still found no change in eng1b expression in either
single or double mutants when compared to WT em-
bryos (Fig. 2h & p, Table 1).
Taken together, these results suggest that V0v cells are
not transfating into V1 cells in zebrafish, even in the ab-
sence of both Evx1 and Evx2. Instead at least most of
these cells are maintaining their V0v identities. In
addition, these data suggest that Evx1 and Evx2 act par-
tially redundantly to maintain each other’s expression,
although only evx2 expression requires Evx1/Evx2 activ-
ity as more than half of V0v cells still express evx1 in
evx1;evx2 double mutants.
Evx1 and Evx2 are required for skor2 expression in V0v
cells
To identify additional transcription factors that might be
required for specification of V0v functional characteristics,
we expression-profiled FAC-sorted V0v cells (see Methods;
[50]). From these analyses, we identified skor2 as a tran-
scription factor gene potentially expressed by V0v neurons.
Our subsequent in situ hybridization experiments demon-
strated that skor2 has two clear domains of spinal cord
expression, a ventral domain and a more dorsal domain
(Fig. 7c). Double labeling experiments show that in the
ventral domain, at least most of the skor2-expressing cells
are V0v cells (Fig. 7a). On average, 97 % of ventral skor2-
expressing cells co-express EGFP in Tg(evx1:EGFP)SU1
embryos (73/75 cells counted in 4 embryos). Given this
high number of double positive cells and the fact that there
is usually a delay in EGFP expression it is possible that
all of the ventral skor2-expressing cells are V0v cells.
Interestingly, double labeling experiments with skor2 and
Tg(slc17a6:EGFP) demonstrated that both the ventral and
dorsal skor2-expressing cells are excitatory cells (Fig. 7b),
suggesting that Skor2 may play in role in specifying excita-
tory fates. As skor2 is expressed by V0v cells, we tested
whether it is regulated by Evx1 and Evx2. We found that
the number of cells expressing skor2 in the ventral spinal
cord is reduced in evx1 and evx2 single mutants compared
to WT embryos. More strikingly, ventral skor2 expression
is completely abolished in double evx1;evx2 mutants
(Figs 7d & e; Table 1), demonstrating that Evx1 and Evx2
are required, partially redundantly for skor2 expression in
V0v cells. In contrast, there was no change in the dorsal
expression of skor2 (Fig. 7d & e; Table 1).
Evx1 and Evx2 are required to specify the glutamatergic
fates of V0v cells
Given that V0v cells still form in the absence of Evx1 and
Evx2 function and their axon trajectories appear to be
unaffected, but expression of a novel excitatory cell marker
skor2 is lost, we decided to test if V0v cell neurotransmitter
phenotypes were changed. When we examined the expres-
sion of slc17a6 (vglut) genes in embryos from a cross
of evx1;evx2 heterozygous parents, we saw a significant
reduction of glutamatergic cells in both of the single mu-
tants when compared to WT embryos and an even more
severe reduction in double mutants (Fig. 8a-d & o; Table 1).
These data indicate that Evx1 and Evx2 act partially redun-
dantly to specify the glutamatergic phenotype of V0v cells.
Strikingly, the number of glutamatergic cells lost in the
double mutant (approximately 28 cells in the spinal
cord region adjacent to somites 6-10) is equivalent to
the number of V0v cells in that region of the spinal
cord (approximately 29 cells express evx2 and 33 cells
express evx1 in this region of the WT spinal cord at this
stage; see Table 1), suggesting that probably all of the
V0v cells have lost their glutamatergic phenotype.
V0v cells become inhibitory in evx1;evx double mutant
embryos
Given that V0v cells lose their excitatory phenotype in
evx1;evx2 double mutants, we asked whether they are
acquiring an inhibitory neurotransmitter fate instead.
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When we examined expression of slc32a1, which is
expressed by all inhibitory neurons [8, 68, 69], there was
no significant difference in the number of cells express-
ing this gene between either of the single mutants and
WT embryos (Fig. 8e, g, h & p, Table 1). However, inter-
estingly, there was a significant increase (approximately
21 cells) in the number of slc32a1-expressing cells in
evx1;evx2 double mutants (Fig. 8f & p, Table 1). This
suggests that Evx1 and Evx2 act redundantly to repress
the inhibitory fate in V0v cells.
To further confirm that V0v cells are switching to an
inhibitory fate, we performed in situ hybridization for
slc32a1 plus immunohistochemistry for EGFP in em-
bryos from a cross of double heterozygous parents that
carry the Tg(evx1:EGFP)SU2 transgene. In WT embryos
we see no co-expression of slc32a1 and EGFP (Fig. 5c).
However, in double mutant embryos most V0v cells ex-
press slc32a1 (77 % of EGFP-positive V0v cells (30/39
cells counted in 2 embryos); Fig. 5f ).
To determine whether V0v cells are becoming GABAer-
gic and/or glycinergic we examined expression of markers
of these two fates. We see no significant difference in the
number of cells expressing GABAergic markers in single
or double mutant embryos (Fig. 8m, n & r). In contrast,
there is an increase in the number of cells expressing
glycinergic markers. Interestingly, and in contrast to the
slc32a1 (viaat) result, we see a slight increase in both
single mutants as well as a more pronounced increase in
double mutants (Fig. 8i-l & q, Table 1). The increase in
double mutants (approximately 28 cells) suggests that all
V0v cells are becoming glycinergic.
V0v cells become glycinergic through a novel Pax2-
independent mechanism
All of the transcription factors that have been identified
so far as specifying inhibitory spinal fates act through
Pax2 [14–21]. In addition, Tlx1 and Tlx3, the only other
transcription factors that have been identified as specify-
ing excitatory spinal cord fates [4, 5, 8], work at least in
part by down-regulating Pax2 [4]. Therefore, we decided
to test if V0v cells turn on Pax2 expression in evx1;evx2
double mutants. However, when we analyzed pax2a ex-
pression there was no significant difference in the num-
ber of cells expressing this gene in either the single or
double mutants compared to WT embryos (Fig. 6b & e;
Table 1). To further confirm this result, we performed
immunohistochemistry using a Pax2 antibody that rec-
ognizes Pax2a and Pax2b [55]. Again, we saw no signifi-
cant change in the number of cells expressing Pax2
protein in single or double mutants (Fig. 6d & f; Table 1).
Finally, we also performed double-labeling experiments
for Pax2 and EGFP in WT and mutant embryos that car-
ried the Tg(evx1:EGFP)SU2 transgene, using either the
Pax2 antibody or in situ hybridization with a mix of
pax2a, pax2b and pax8 probes. In each case we exam-
ined at least two WT embryos and two double homozy-
gous mutants and we did not observe any double-
labeled cells (Fig. 6h and data not shown).
Taken together these results show that V0v cells
are becoming glycinergic through a Pax2-independent
mechanism. This is the first time that a Pax2-
independent mechanism of glycinergic specification has
been identified in spinal cord neurons.
Table 1 Number of cells expressing particular genes and proteins in WT and mutant embryos
Marker Stage WT evx1 mutants Pa evx2 mutants Pb Double mutants Pc Pd Pe
evx1 24 h 33.0 + /-2.0 31.0 + /-3.3 0.32 31.3 + /-2.5 0.56 17.4 + /-2.6 <0.01 <0.01 <0.01
evx2 24 h 28.6 + /-1.6 22.4 + /-50 0.02 13.5 + /-3.5 <0.01 0.00 <0.01 <0.01 <0.01
Evx2 30 h 33.6 + /-5.2 23.0 + /-4.6 0.01 N.D N.D
eng1b 24 h 43.3 + /-2.5 43.6 + /-2.0 0.80 43.5 + /-4.0 0.94 37.2 + /-6.0 0.08 0.07 0.10
eng1b 30 h 63.0 + /-3.0 62.0 + /-2.5 0.63 63.0 + /-2.5 0.92 65.2 + /-2.0 0.15 0.06 0.15
slc17a6 (vlgut) 24 h 89.0 + /-10.0 71.3 + /-4.3 <0.01 74.6 + /-8.0 0.01 60.8 + /-10 <0.01 0.08 0.04
slc32a1 (viaat) 24 h 157.4 + /-8.0 157.3 + /-10.0 0.75 158.2 + /-4.0 0.86 178.6 + /-7.0 <0.01 <0.01 <0.01
gads (GABAergic) 24 h 50.0 + /-3.0 49.0 + /-4.0 0.59 51.6 + /-2.6 0.31 50.6 + /-2.2 0.66 0.38 0.5
slc6a5 (glyt2a/glyt2b) 24 h 81.0 + /-3.3 93.0 + /-9.0 <0.01 87.6 + /-4.5 0.02 109 + /-10.0 <0.01 0.02 <0.01
pax2a 24 h 50.6 + /-2.6 50.4 + /-2.0 0.86 49.5 + /-30 0.55 50.8 + /-2.5 0.91 0.75 0.49
Pax2 24 h 40.3 + /-3.8 39.8 + /-5.7 0.83 36.9 + /-6.9 0.23 38.8 + /-5.3 0.41 0.68 0.52
skor2 30 h 24.3 + /-3.0 15.0 + /-5.0 <0.01 19.8 + /-4.0 0.07 0.0 <0.01 <0.01 <0.01
skor2 Total cell counts 30 h 46.7 + /-3.7 38.7 + /-3.3 <0.01 42.4 + /-1.7 0.04 22.6 + /-1.7 <0.01 <0.01 <0.01
Numbers of cells expressing particular markers (first column on left) in spinal cord region adjacent to somites 6-10 and P values of comparisons between
embryos with different genotypes. Values are shown as the mean from at least 5 different embryos +/- standard deviation, except for pax2a and eng1b where 4
embryos were counted. P values are from student’s t-tests. Statistically significant (P < 0.05) values are indicated in bold. Pa compares evx1 single mutants with
WT embryos, Pb compares evx2 single mutants with WT embryos, Pc, Pd and Pe are for comparisons between double mutant embryos and WT (Pc), evx1 single
mutant (Pd) and evx2 single mutant (Pe) embryos respectively. Mean cell count values are provided to one decimal place and P values to two decimal places. For
skor2, two sets of values are provided: just the ventral domain of expression and both the ventral and dorsal domains of expression (total cell counts)
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Discussion
Evx genes are found in a wide range of animals ranging
from corals to humans [72]. They encode transcription
factors that contain both DNA-binding homeobox and
C-terminal repressor domains [73–77]. Amniotes have
two Evx genes (Evx1 and Evx2) and teleosts, including
zebrafish, have three (evx1, evx2 and eve1), although
only evx1 and evx2 are expressed in the spinal cord
([26, 32, 33, 59, 64]; this paper Figs. 2, 3, Additional file
1: Results and Figure S1). Interestingly, the genomic
Fig. 7 skor2 is expressed by V0v cells and this expression is lost in evx1;evx2 double mutants. Lateral views of zebrafish spinal cord at
27 h (a) and 30 h (b-d). Anterior left, dorsal top. a & b Merged images on top followed by single-channel views. Panels on RHS are
single confocal planes of white dashed-box regions. Stars indicate double-positive cells. a Expression of skor2 (red) and EGFP (green) in
Tg(evx1:EGFP)SU1 embryo. In this example, all ventral skor2-expressing cells co-express EGFP. On average, 97 % of ventral skor2-expressing
cells co-express EGFP (73/75 cells counted in 4 embryos). In contrast, about 57.5 % of V0v cells co-express skor2 (73/127 cells counted in
4 embryos). b Expression of skor2 (red) and EGFP (green) in Tg(slc17a6:EGFP) embryo that labels glutamatergic cells. Crosses indicate cells
that are only clearly positive for skor2. On average 93.5 % of skor2-expressing cells co-express EGFP (201/215 cells counted in 4 embryos).
As there is usually a delay in EGFP expression it is possible that all ventral skor2-expressing cells are excitatory V0v cells, as the small
number of ventral skor2-positive EGFP-negative cells may be just starting to express EGFP. c & d Expression of skor2 (blue) in both WT
(c) and evx1;evx2 double mutant (d) embryos. The ventral row of skor2 expression is lost in double mutants. e Average number of cells
(y-axis) expressing skor2 in spinal cord region adjacent to somites 6-10 in WT embryos and evx1 and evx2 single and double mutants
(x-axis) at 30 h. Results are shown for the ventral (V0v) domain of skor2 expression and for the whole skor2 expression domain (total cell
counts). Values are mean +/- standard deviation (also see Table 1). In each case at least 5 embryos were counted. Statistically significant
differences (P < 0.05) from WT values are indicated with stars. P values for all comparisons are provided in Table 1. Scale bar: 50 μm
(a & b); 40 μm (c & d)
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positions of these evx genes (adjacent to specific Hox
clusters) along with phylogenetic analyses strongly sug-
gest that the third evx gene in teleosts (eve1) is not the
result of the extra genome duplication in the teleost
lineage ([26, 78, 79], Additional file 1). Instead, it is likely
that all three of these genes originated from the two
rounds of whole genome duplication that occurred early
in the vertebrate lineage [80] and eve1 was later lost in
the tetrapod lineage ([26, 78], Additional file 1).
Here we provide the first comprehensive analysis of
the functions of Evx1 and Evx2 in spinal cord inter-
neuron development in any vertebrate. We demonstrate
that, within the spinal cord, both of these transcription
factors are expressed exclusively by V0v cells. We also
show that V0v cells are glutamatergic. These findings
complement and extend those of Satou and colleagues
[36], who reported that Evx2-expressing cells that
develop from the dbx1b progenitor domain in zebrafish
express the glutamateric maker slc17a6b and Talpalar
and colleagues [9], who showed that mouse V0v cells
express the glutamatergic marker slc17a6 (vglut2). In
addition, we confirm and extend previous reports that
suggested that V0v neurons extend commissural axons
[23, 27, 35, 36] and we identify these neurons as CoSA
interneurons. Interestingly, while Satou and colleagues
[36] observed similar V0v cell morphologies at the stages
that we have examined, at later stages of development
they also saw descending and bifurcating commissural
excitatory V0 cells, suggesting that V0v cells may diver-
sify morphologically at later developmental stages [36].
In mouse Evx1 mutants, most V0v cells completely
change their fate and acquire characteristics of V1 cells,
the cell-type that normally forms ventral to V0v cells.
Cells that would have formed V0v interneurons lose
Fig. 8 Neurotransmitter phenotypes in evx1;evx2 double mutant embryos. Lateral views of zebrafish spinal cord at 24 h (a-n). Anterior is left,
dorsal up. in situ hybridization for gene or genes indicated. slc17a6 (a-d) corresponds to a mix of slc17a6b and slc17a6a probes that label
glutamatergic cells; slc32a1 (e-h, formerly called viaat) labels all inhibitory cells; slc6a5 (i-l) labels glycinergic cells and gads (m & n) corresponds to
a mix of gad1a and gad2 probes that labels GABAergic cells (see methods for more details). o-r Average number of cells (y-axis) expressing these
markers (indicated in each case) in spinal cord region adjacent to somites 6-10 in WT embryos and evx1 and evx2 single and double mutants
(x-axis) at 24 h. Values are shown as mean +/- standard deviation (values are provided in Table 1). In each case at least 5 embryos were counted.
Statistically significant differences (P < 0.05) from WT values are indicated with brackets and stars. P values for all comparisons are provided in
Table 1. Scale bar: 50 μm (a-n)
Juárez-Morales et al. Neural Development  (2016) 11:5 Page 15 of 20
expression of Evx1 and Evx2 and instead express the V1
marker Engrailed1 (En1) and develop axon trajectories
and migration patterns characteristic of V1 interneurons
[23]. Most notably, their axon trajectories change from
being contralateral to ipsilateral [23]. In addition, experi-
ments in chick embryos revealed that ectopic Evx is suf-
ficient to suppress Engrailed expression and therefore
presumably V1 cell fate [23]. The role of Evx2 in mouse
V0v cells is less well understood. Evx2 expression is
dependent on Evx1, suggesting that it may be involved
in the specification events described above [23], but
spinal cord phenotypes of Evx2 mutants have not been
described in mouse and before this study, Evx1;Evx2
double mutants had not been described in any
vertebrate.
These amniote data suggest that Evx1 is required to
inhibit the V1 fate in post-mitotic V0v cells. This global
cell fate change is unusual for a transcription factor
expressed in post-mitotic cells: it is more commonly
seen with transcription factors expressed in spinal pro-
genitor domains (e.g. [27–29, 81, 82]). For example,
Nkx2.2 is a transcription factor expressed in the p3 pro-
genitor domain and in Nkx2.2 mutant mice, cells that
would have formed V3 interneurons change their fates
(transfate) and become motoneurons instead [83]. Simi-
larly, Dbx1 is expressed in the progenitor domain (p0)
from which V0 cells develop and in Dbx1 mutant mice,
cells that would have become V0v cells assume the char-
acteristics of V1 cells [27, 28].
Interestingly, our results are different and yield novel
insights into Evx1 and Evx2 function in the spinal cord.
We see no evidence of V0v cells transfating to V1 cells
in zebrafish evx1 and evx2 single or double mutants.
Notably, there is no increase in the number of cells ex-
pressing eng1b, which is specifically expressed in V1
cells, or Pax2, which is expressed by V1 and V0D cells.
Instead most V0v cells continue to express evx1 mRNA
and Tg(evx1:EGFP) and these EGFP-labelled V0v neu-
rons have what appear to be normal CoSA axon morph-
ologies. These data strongly suggest that V0v cells still
form in zebrafish evx1;evx2 double mutants and that
they do not become a different class of neuron. One
possible explanation for the differences between our re-
sults and the previously reported analyses in mouse
might be evolutionary changes in the functions of Evx1
and Evx2. However, it is also possible that the conse-
quences of removing these transcription factors are dif-
ferent in mouse and zebrafish because of variations in
the expression of Dbx1 and/or the timing of V0v devel-
opment. Interestingly, in this paper, we have shown that
expression of dbx1a and dbx1b persists in at least some
V0v cells in zebrafish. Therefore, it is possible that in
zebrafish evx1;evx2 mutants, Dbx might be able to in-
hibit post-mitotic V0v cells from becoming V1 cells
(Fig. 9). Given the speed of zebrafish spinal cord devel-
opment it is also possible that V0v cells become com-
mitted to their fate faster than in mouse and that,
therefore, the window of time during which the V1 fate
needs to be inhibited in V0v cells is much shorter in
zebrafish than in mammals (see [84] for a different ex-
ample of how the fast speed of zebrafish development
can produce changes in spinal cord development). Re-
gardless of how V0v global cell fate specification has
evolved, the fact that V0v cells still form in zebrafish
lacking Evx1 and Evx2, has provided us with a unique
opportunity to identify Evx functions in V0v cells, inde-
pendent of any role that these transcription factors may
also have in repressing the V1 cell fate.
Our results show that in zebrafish, Evx1 and Evx2
act partially redundantly to specify the glutamatergic
fate of V0v cells and inhibit an alternative glycinergic
fate in these cells. Given that the only spinal cord
cells that express evx1 and evx2 are V0v cells and
that the only other trunk tissue that expresses either
of these genes is the posterior gut, which expresses
evx1, we consider that this requirement for Evx1 and
Evx2 function is likely to be cell-autonomous. Inter-
estingly, while there is a reduction of glutamatergic
cells in both single and double mutants, expression of
the inhibitory marker slc32a1 is only increased in
double mutants, suggesting that the specification of
glutamatergic fates and the inhibition of glycinergic
fates may be independent processes which require dif-
ferent levels of Evx activity. However, in contrast to
slc32a1, the number of cells expressing the glycinergic
marker slc6a5 was slightly increased in single mu-
tants, which suggests that the expression of different
neurotransmitter transporter proteins is regulated in-
dependently and by distinct levels of Evx activity.
These results are intriguing as they suggest that the
regulation of neurotransmitter transporters and en-
zymes might be complex, with different components
being regulated by distinct mechanisms.
V0v interneurons are a crucial part of locomotor
circuitry as they are required for hindlimb left-right
alternation during fast locomotion [9, 27, 34]. There-
fore, changing the neurotransmitter fate of these cells
might be expected to impair fast movements. Unfor-
tunately, as evx2 mutants die by larval stages, we
were not able to assess whether evx2 single mutants
or evx1;evx2 double mutants have locomotion defects.
In addition, evx1 single mutants lack joints in their
fins [39], making it impossible to evaluate if any
difference in evx1 single mutant behavior is due to
this fin phenotype or a locomotive defect. Interest-
ingly, we did not observe any obvious changes in V0v
cell morphology or axon trajectory in evx1;evx2
double mutants. Given the changed neurotransmitter
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phenotype of V0v cells in these animals this might be
considered surprising, although it is consistent with
our previous analysis of V1 cells, that maintain their
ipsilateral axon trajectories even when they lose their
inhibitory fates in the absence of Pax2 and Pax8 [14].
It is still possible though that there are subtle
changes in V0v cell wiring and/or changes in V0v cell
connectivity in evx1;evx2 double mutants as a result
of their change in neurotransmitter fate. As there are
fewer GFP-labelled V0v cells in evx1;evx2 double mu-
tants it is also possible that V0v cells with inappropri-
ate neurotransmitter fates eventually die, although
alternatively this reduction in the number of GFP-
positive cells may just reflect autoregulation of Evx
expression.
In this paper, we also describe the expression of a
different transcription factor gene expressed by V0v
cells, skor2. Skor2 expression has also been reported
in the mouse spinal cord but the cells that express it
were not identified [85]. Our results show that skor2
is expressed by a subset of V0v cells as well as at least one
population of more dorsal excitatory spinal cord cells.
We also demonstrate that expression of skor2 in V0v
cells requires Evx1 and Evx2 activity. Given that skor2
is predominantly expressed by excitatory cells, it is pos-
sible that it acts downstream of Evx1 and Evx2 in V0v
cells in either the specification of glutamatergic fates
and/or the inhibition of glycinergic fates and that it
might also have this function in other cells. However it
is also possible that Skor2 acts downstream of Evx1 and
Evx2 in some other as-yet-unidentified aspect of V0v
cell specification. These alternatives can be tested by
future loss-of-function analyses of Skor2.
Excitingly, in addition to demonstrating the roles of
Evx1 and Evx2 in neurotransmitter specification, our data
also show that these transcription factors function inde-
pendently of Pax2 in specifying glutamatergic fates and
inhibiting glycinergic fates. This is the first time that a
Pax2-independent mechanism of inhibitory fate specifica-
tion has been identified in the spinal cord. While several
transcription factors have been identified that specify the
inhibitory fates of particular spinal cord neurons, so far all
of these act upstream of Pax2 [14–18]. In addition, as
mentioned before, the only other transcription factors that
Fig. 9 A Model for Evx Function in V0v cells. A possible model that would reconcile the different phenotypes of mouse and zebrafish Evx1
mutants. In this model, Dbx1 expression in P0 cells is required for the expression of Evx1 and Evx2 in V0v cells (for simplicity this interaction is not
shown) and Dbx1 can also independently repress the V1 fate. In zebrafish, Dbx1 expression persists for a while in newly formed V0v cells. This
may be sufficient for the V1 fate to be inhibited in post-mitotic V0v cells, even in the absence of Evx1 and Evx2, thereby revealing other functions
of Evx transcription factors. This could explain why V0v cells still form in evx1;evx2 double mutants, but they express glycinergic rather than gluta-
matergic markers. In contrast, in mouse Dbx1 is expressed only in progenitor cells. Therefore, in newly formed V0v cells only Evx1 and Evx2 inhibit
the V1 fate and in the absence of these transcription factors V0v cells transfate into V1 cells
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have been identified as specifying excitatory spinal cord
fates, Tlx1 and Tlx3 [4, 5, 8], work at least in part by
down-regulating Pax2 [4]. Therefore, our finding that V0v
cells become inhibitory in evx1;evx2 double mutants but
do not express Pax2 is a significant one as it demonstrates
that there must be an additional Pax2-independent mech-
anism for specifying inhibitory neurons in the spinal cord.
Conclusions
In conclusion, in this paper we demonstrate that zebrafish
V0v cells express evx1 and evx2 and develop into excitatory
(glutamatergic) CoSA interneurons. We also show that
Evx1 and Evx2 are required, partially redundantly for ex-
pression of skor2 and glutamatergic markers and inhibition
of glycinergic markers in V0v cells and that in the absence
of Evx1 and Evx2 function V0v cells become glycinergic
through a novel Pax2-independent mechanism. Taken
together, our data significantly increase our understanding
of how neurotransmitter fates are specified and the genetic
networks involved in these processes.
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